FDA Approves New Labeling for ISENTRESS(R) (raltegravir) to Include 1...  - CNBC

WHITEHOUSE STATION, N.J., May 21, 2012 (BUSINESS WIRE) -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved a labeling update for ISENTRESS(R) (raltegravir) Film ...

US FDA approves labelling update for Merck's Isentress - pharmabiz.com

The US Food and Drug Administration (FDA) has approved a labelling update for Merck's, known as MSD outside the United States and Canada, Isentress (raltegravir) film-coated tablets to include 156-week data from the STARTMRK study with Isentress in ...

Merck Says FDA Approved Labeling Update For ISENTRESS - Quick Facts - RTT News

(RTTNews) - Merck (MRK: News ) said the FDA approved a labeling update for ISENTRESS (raltegravir) Film-coated Tablets to include 156-week data from the STARTMRK study with ISENTRESS in combination therapy compared to efavirenz in combination therapy in ...

Walt Disney and 2 Dow 30 Stocks Making Waves - Wall St. Cheat Sheet

Merck & Co. Inc. (NYSE:MRK) has been granted FDA approval for a labeling update for Isentress Film-coated Tablets, which include 156 weeks of data from the StartMRK evaluation with Isentress, in combination therapy compared to efavirenz in combination ...

Gilead's Crucial AIDS Pill Gets Thumbs Up - Forbes

The medication is seen as crucial to Gilead’s future and poses a threat to Merck’s rival pill, Isentress, which must be taken twice a day. Thomas Russo, an analyst at R.W. Baird, writes: Continue to recommend overweight positions in GILD ...

Analysis And Valuation: Johnson & Johnson, Pfizer, And Merck - Seekingalpha.com

Pharmaceutical sales are increasing, although pharma sales have been relatively flat recently. The FDA approved new labeling for Isentress (raltegravir) to include 156-week data demonstrating long-term efficacy, safety and tolerability with Isentress in ...

Merck: Will Singulair Expiration Sink Its Stock? - Seekingalpha.com

Isentress is used in combination therapy to treat HIV infection. Gardasil is a vaccine for human papilloma virus, which causes genital warts in men and cervical and other cancers in women. Gardasil may be Merck's most interesting product. A cancer vaccine ...

AIDS Advocates to Protest Gilead over Drug Pricing at May 10th Shareholders’ Meeting - StreetInsider.com

Chief among them is Gilead Sciences’ so-called “Quad”. The “Quad” combines Truvada with Elvitegravir (an integrase inhibitor similar to Merck’s Isentress) and Cobicistat (a blood booster similar to the decade-old Norvir). The FDA is currently ...